http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017102125-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_adff709a8d25eaa0d3871ff46ff250eb |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
| filingDate | 2017-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad427faf76bf28e585141b95bccd87d7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ecf5874b7b757deef6ee5b1e36af957 |
| publicationDate | 2017-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2017102125-A |
| titleOfInvention | Assay system for assessment of oncogenicity, tumor progression, and treatment efficiency |
| abstract | A system and kit are provided that can determine the oncogenicity of cancer, tumor progression, and efficacy of cancer treatment. To determine the tumorigenicity of a cancer, tumor progression, and the effectiveness of cancer treatment using an assay to examine the levels of apoptosis markers, angiogenesis markers, immunoregulatory markers, and cell cycle markers, Systems and kits that can compare samples from patients taken at different time points. A method of determining the oncogenicity, tumor progression, and efficacy of cancer treatment of cancer along with such systems and kits. [Selection figure] None |
| priorityDate | 2008-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 159.